DK1808165T3 - Törre formuleringer af aripiprazol - Google Patents

Törre formuleringer af aripiprazol

Info

Publication number: DK1808165T3
Authority: DK; Denmark
Prior art keywords: aripiprazole; dry formulations; tablets; compositions; dry compression
Prior art date: 2006-01-05

Application number

DK06251325T

Other languages

Danish (da)

English (en)

Inventor

Julia Hrakovsky

Ruth Tenengauzer

Original Assignee

Teva Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-01-05

Filing date

2006-03-14

Publication date

2009-08-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36617397&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1808165(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-03-14 Application filed by Teva Pharma filed Critical Teva Pharma

2009-08-03 Application granted granted Critical

2009-08-03 Publication of DK1808165T3 publication Critical patent/DK1808165T3/da

Links

CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title abstract 2
229960004372 aripiprazole Drugs 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
238000009472 formulation Methods 0.000 title 1
230000006835 compression Effects 0.000 abstract 2
238000007906 compression Methods 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK06251325T 2006-01-05 2006-03-14 Törre formuleringer af aripiprazol DK1808165T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US75670706P	2006-01-05	2006-01-05

Publications (1)

Publication Number	Publication Date
DK1808165T3 true DK1808165T3 (da)	2009-08-03

Family

ID=36617397

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06251325T DK1808165T3 (da)	2006-01-05	2006-03-14	Törre formuleringer af aripiprazol

Country Status (14)

Country	Link
US (2)	US20070154545A1 (pt)
EP (1)	EP1808165B1 (pt)
JP (1)	JP2008531738A (pt)
CN (1)	CN101351193A (pt)
AT (1)	ATE429906T1 (pt)
CA (1)	CA2627695A1 (pt)
DE (1)	DE602006006536D1 (pt)
DK (1)	DK1808165T3 (pt)
ES (1)	ES2325219T3 (pt)
HK (1)	HK1104795A1 (pt)
IL (1)	IL190915A0 (pt)
PL (1)	PL1808165T3 (pt)
PT (1)	PT1808165E (pt)
WO (1)	WO2007081367A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200604349A2 (tr) *	2006-08-15	2008-03-21	NOBEL İLAÇ SANAYii VE TiCARET A.Ş.	Aripiprazol içeren farmasötik bileşimler
GB0618879D0 (en)	2006-09-26	2006-11-01	Zysis Ltd	Pharmaceutical compositions
WO2010079506A2 (en) *	2008-06-23	2010-07-15	Torrent Pharmaceuticals Ltd.	Pharmaceutical composition of aripiprazole
WO2011032882A1 (en)	2009-09-15	2011-03-24	Ratiopharm Gmbh	Orally disintegrating pharmaceutical dosage form containing aripiprazole
TR201000948A1 (tr) *	2010-02-09	2011-08-22	Sanovel İlaç San.Ve Ti̇c.A.Ş.	Aripiprazol formülasyonları.
CN103379901B (zh) *	2010-11-30	2018-04-03	维斯塔实验室有限公司	含有氯化甲基息奥宁的配方
CN102850268B (zh) *	2011-06-27	2015-07-15	上海中西制药有限公司	阿立哌唑ⅰ型微晶、阿立哌唑固体制剂及制备方法
WO2013175508A2 (en)	2012-05-24	2013-11-28	Medreich Limited	Stable pharmaceutical composition of aripiprazole
US9051268B2 (en)	2013-04-30	2015-06-09	Otsuka Pharmaceutical Co., Ltd.	Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
JP2016204260A (ja) *	2013-10-04	2016-12-08	日本曹達株式会社	錠剤の製造方法
EP3065700A1 (en) *	2013-11-07	2016-09-14	Synthon B.V.	Orodispersible pharmaceutical compositions comprising aripiprazole
CN106943405B (zh) *	2016-01-06	2021-04-06	上海中西制药有限公司	一种阿立哌唑制剂及其制备方法
KR20190003805A (ko) *	2016-05-27	2019-01-09	한미약품 주식회사	암 세포 성장을 저해하는 아민 유도체 또는 이의 약학적으로 허용가능한 염 및 저융점을 갖는 안정화제를 포함하는 약학적 조성물
CN108014343A (zh) *	2017-12-21	2018-05-11	孟斯琴	一种治疗乳腺癌的药物组合物及其制备方法
CN111213650A (zh) *	2020-02-25	2020-06-02	晋江市老君日化有限责任公司	一种蚊香的制备工艺

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2311734C (en) *	2000-04-12	2011-03-08	Bristol-Myers Squibb Company	Flash-melt oral dosage formulation
MY129350A (en) *	2001-04-25	2007-03-30	Bristol Myers Squibb Co	Aripiprazole oral solution
AR033485A1 (es) *	2001-09-25	2003-12-26	Otsuka Pharma Co Ltd	Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
TWI324074B (en) *	2001-10-09	2010-05-01	Bristol Myers Squibb Co	Flashmelt oral dosage formulation
JP2003238393A (ja) *	2002-02-15	2003-08-27	Otsuka Pharmaceut Co Ltd	施錠性が改善された錠剤及びその製造方法
DE10224170A1 (de) *	2002-05-31	2003-12-11	Desitin Arzneimittel Gmbh	Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung
WO2004083183A1 (en) *	2003-03-21	2004-09-30	Hetero Drugs Limited	Novel crystalline forms of aripiprazole
EP1618103A2 (en) *	2003-04-25	2006-01-25	Cadila Healthcare Ltd.	Polymorphs of aripiprazole
BRPI0415531B8 (pt) *	2003-10-23	2021-05-25	Otsuka Pharma Co Ltd	formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
ATE529409T1 (de) *	2003-12-16	2011-11-15	Teva Pharma	Verfahren zur herstellung von kristallinen aripiprazolformen
US7507823B2 (en) *	2004-05-06	2009-03-24	Bristol-Myers Squibb Company	Process of making aripiprazole particles
CN102627603A (zh) *	2004-11-18	2012-08-08	斯索恩有限公司	制备结晶阿立哌唑的方法
EP1812396A1 (en) *	2004-11-18	2007-08-01	Synthon B.V.	Crystalline aripiprazole solvates
EP1686117A1 (en) *	2005-01-27	2006-08-02	Sandoz AG	Polymorph and solvates of aripiprazole
ES2526415T3 (es) *	2005-03-17	2015-01-12	Synthon B.V.	Comprimidos farmacéuticos de aripiprazol cristalino de tipo II
AU2006247482A1 (en) *	2005-05-13	2006-11-23	Lexicon Pharmaceuticals, Inc.	Multicyclic compounds and methods of their use
US20070014853A1 (en) *	2005-07-15	2007-01-18	Ilan Zalit	Pharmaceutical dosage form containing novel pharmaceutical granulate
US20070014854A1 (en) *	2005-07-15	2007-01-18	Ilan Zalit	Novel granulation process
US20070014864A1 (en) *	2005-07-15	2007-01-18	Teva Pharmaceutical Industries, Ltd.	Novel pharmaceutical granulate
CA2622758A1 (en) *	2005-09-15	2007-03-29	Elan Pharma International, Limited	Nanoparticulate aripiprazole formulations
JP2008537540A (ja) *	2005-12-22	2008-09-18	テバファーマシューティカルインダストリーズリミティド	アリピプラゾールの粒径を小さくする方法
US20070148245A1 (en) *	2005-12-22	2007-06-28	Ilan Zalit	Compressed solid dosage forms with drugs of low solubility and process for making the same
EP1880714A1 (en) *	2006-07-20	2008-01-23	Helm AG	Amorphous Aripiprazole and Process for the Preparation thereof

2006
- 2006-03-14 AT AT06251325T patent/ATE429906T1/de not_active IP Right Cessation
- 2006-03-14 PT PT06251325T patent/PT1808165E/pt unknown
- 2006-03-14 ES ES06251325T patent/ES2325219T3/es active Active
- 2006-03-14 PL PL06251325T patent/PL1808165T3/pl unknown
- 2006-03-14 CA CA002627695A patent/CA2627695A1/en not_active Abandoned
- 2006-03-14 DK DK06251325T patent/DK1808165T3/da active
- 2006-03-14 DE DE602006006536T patent/DE602006006536D1/de active Active
- 2006-03-14 CN CNA200680050282XA patent/CN101351193A/zh active Pending
- 2006-03-14 JP JP2007558353A patent/JP2008531738A/ja active Pending
- 2006-03-14 EP EP06251325A patent/EP1808165B1/en not_active Revoked
- 2006-03-14 US US11/376,472 patent/US20070154545A1/en not_active Abandoned
- 2006-03-14 WO PCT/US2006/009280 patent/WO2007081367A1/en active Application Filing
2007
- 2007-12-05 HK HK07113266.3A patent/HK1104795A1/xx not_active IP Right Cessation
2008
- 2008-04-16 IL IL190915A patent/IL190915A0/en unknown
2013
- 2013-06-19 US US13/921,713 patent/US20130344146A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2008531738A (ja)	2008-08-14
DE602006006536D1 (de)	2009-06-10
WO2007081367A1 (en)	2007-07-19
ATE429906T1 (de)	2009-05-15
US20070154545A1 (en)	2007-07-05
HK1104795A1 (en)	2008-01-25
ES2325219T3 (es)	2009-08-28
CN101351193A (zh)	2009-01-21
US20130344146A1 (en)	2013-12-26
EP1808165B1 (en)	2009-04-29
EP1808165A1 (en)	2007-07-18
PT1808165E (pt)	2009-06-09
IL190915A0 (en)	2008-11-03
CA2627695A1 (en)	2007-07-19
PL1808165T3 (pl)	2009-09-30

Publication	Publication Date	Title
DK1808165T3 (da)	2009-08-03	Törre formuleringer af aripiprazol
ATE528989T1 (de)	2011-11-15	Kristalline feste rasagilin-base
DK1808164T3 (da)	2009-04-20	Vådgranuleringsmetode til fremstilling af farmaceutiske sammensætninger af aripiprazol
PH12015500550A1 (en)	2016-06-13	Anti-notch1 nrr antibodies and methods using same
IL193074A0 (en)	2009-02-11	Stable pharmaceutical formulations of montelukast sodium
WO2008121767A3 (en)	2009-01-08	Stitched polypeptides
UY30225A1 (es)	2007-10-31	Composiciones farmacéuticas
DK3219705T3 (da)	2020-04-14	Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
IL204844A (en)	2017-01-31	Coinolone analogues, pharmaceuticals containing them and their uses
WO2007127834A3 (en)	2011-09-22	Compositions and methods of preparation thereof
WO2007109604A3 (en)	2009-04-09	Pharmaceutical compositions
ATE526318T1 (de)	2011-10-15	Farnesoid-x-rezeptor-agonisten
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
IL195488A (en)	2017-04-30	Compounds, pharmaceuticals containing them and their uses
BRPI0913379A2 (pt)	2015-11-24	formulações farmacêuticas sólidas compreendendo bibw 2992
WO2008057550A3 (en)	2009-04-02	Stabilization of vaccines by lyophilization
EA200601596A1 (ru)	2007-04-27	Улучшенный состав 6-меркаптопурина
CL2007001838A1 (es)	2008-02-08	Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
WO2006091836A8 (en)	2007-04-12	Formulations of ladostigil tartrate
BRPI0812234A2 (pt)	2014-12-16	Composto de quinolona e composição farmacêutica.
WO2007087026A3 (en)	2007-09-13	Solid-state form of amg 706 and pharmaceutical compositions thereof
FR2923834B1 (fr)	2011-01-21	Nouvelles compositions polysicocyanates hydrodispersibles.
BRPI0614413A2 (pt)	2016-11-22	composto, e, composição farmacêutica
EA200600590A1 (ru)	2006-08-25	Фармацевтические композиции модафинила с модифицированным высвобождением
BRPI0614412A2 (pt)	2016-11-22	composto, e, composição farmacêutica